RELATED: This Uncommon Supplement Can Improve Your Sleep and Mood, New Study Says.

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

Georgia, Notre Dame fans make Sugar Bowl decision as game is postponed over terror attack A Little Boy Found a Strange Stone ...

The rent-to-own policy, in particular, epitomizes this broken system. It penalizes patients who depend on critical medical ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

What many dismiss as a mere nighttime nuisance often signals deeper health issues requiring medical attention. While snoring ...

From sleep apnea notifications to a number of new health and fitness tools, WatchOS 11 adds a lot of new functionality to ...

“People who experience SRED are at an increased risk of fatigue, depression and weight gain,” Johnston said. They’re also at ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

The sleep disorders center at Bradford Regional Medical Center achieved a milestone in patient care by completing over 1,000 ...

According to the American College of Sports Medicine, the No. 1 trend for 2025 is wearable technology.